Navigation Links
Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination
Date:5/20/2008

rrett's esophagus and early esophageal cancer."

A related study presented last year in May 2007 at an international gastroenterology meeting reported that ablative therapy, as used in this trial, eradicated all the associated genetic abnormalities of the early cancer and dysplasia in treated patients.

A current standard of treatment for advanced dysplasia and early cancer of the esophagus is surgical removal of the esophagus (i.e. esophagectomy.) This surgical procedure is often associated with significant patient morbidity and even mortality. Once cancer occurs, the five year survival is poor. According to the American Cancer Society, 16,470 new diagnoses and 14,280 deaths due to esophageal cancer will occur this year in the U.S.

About BARRX Medical, Inc.

BARRX Medical, Inc. develops treatment solutions for Barrett's esophagus, a precancerous condition of the lining of the esophagus (swallowing tube) caused by gastroesophageal reflux disease, or GERD. Its flagship product, the HALO360 System, provides uniform and controlled therapy at a consistent depth, which can remove Barrett's esophagus and allow the re-growth of normal cells. In the largest study conducted (AIM-II Trial), 98 percent of patients were Barrett's-free after two and a half years. The system used in the clinical trials was cleared by the U.S. Food and Drug Administration in 2001 and has been commercially available since January 2005. Over 14,000 procedures have been performed in over 200 hospitals around the world. Based in Sunnyvale, Calif., BARRX Medical, Inc. was founded in 2000 and is privately-held. Additional information about BARRX Medical, Inc. and the HALO ablation system of products is available at http://www.barrx.com.

About Endoscopy

Endoscopy, the official publication for the European Society of Gastrointestinal Endoscopy (ESGE), publishes original, peer-reviewed articles on endoscopic procedures
'/>"/>

SOURCE BARRX Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Saving Lives of California Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment
3. Saving Lives of Florida Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment
4. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
5. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
6. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
7. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response
10. Study Protocols Will be Amended in Two Small Early-Phase Prasugrel Studies
11. Potential Early Warning System for Lung Cancer Identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ewswire/ -- FluoroPharma Inc., a company developin...sitron Emission Tomography,(PET) market, announced...orine-18 labeled tracer for myocardial perfusion i...lar product to complete Phase I clinical,developme...sess the blood flow in the,heart (myocardial perfu...
(Date:7/23/2008)...23 /- InCode BioPharmaceutics, Inc.,...nced preclinical test,results demonstrating the ut...reatment of the rare chronic blood disorder paroxy...results will be presented at the XXII,Internationa...mber 28,2008., The only treatment currently avai...
(Date:7/23/2008)...ND-Enabling Work with Protein Therapeutics that ... System, CAMBRIDGE, Mass., July 23 /... initiated a corporate growth plan with the,appoin... officer and the,establishment of its headquarters...f Emlen, M.D., a co-founder of the company who rem...
(Date:7/22/2008)...sults from a multi-center 293-patient European, t... Exchange Symbol: CYT, MONTREAL, July 22 /PRNewsw...e global leader in cryotherapy products to treat c...reviously presented from three,European study cent...(R),were published earlier today in the Journal o...
Breaking Medicine Technology:FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Access Highlighted in Recent BusinessWeek Article 498 1Access Highlighted in Recent BusinessWeek Article 498 2Prescription labels geared toward pharmacies not patients 982 1Prescription labels geared toward pharmacies not patients 982 2Scientists fear rare dolphin driven to extinction by human activities 345 1Scientists fear rare dolphin driven to extinction by human activities 345 2IVCC launches groundbreaking insecticide projects with Bayer and Syngenta 978 1IVCC launches groundbreaking insecticide projects with Bayer and Syngenta 978 2
(Date:7/25/2008)...ncial results -, LAVAL, QC, July 25 /PRNewswire-F...) today announced that it will host a conference c...ss its second quarter 2008,financial results. Labo...l,results via news release at approximately 7:00 a...by telephone, dial 416-646-3095 or,1-800-814-4859....
(Date:7/25/2008)...stCall/ -- Thoratec,Corporation (Nasdaq: THOR ) a...ry support therapies to save, support and restore ...t its operating results for the second,quarter and... 31., The company will hold a conference call to ...ties to all interested parties at 1:30 p.m.,Pacif...
(Date:7/25/2008)...unction, increases asthma risk, studies find, ,... clean, fresh-smelling home may actually be bad fo...and air freshening products you use. , Recent r...s or air fresheners that contain a certain volatil...ne (1,4 DCB), can reduce lung function by 4 percen...
(Date:7/25/2008)... Society for Gastrointestinal Endoscopy (ASGE) has... bariatric surgery patient. The rising prevalence ... surgical interventions led to a marked increase i... the U.S., from 13,365 in 1998 to 102,794 in 2003....ive patient and the postoperative patient, and app...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3
...nder affects learning have found that boys and gir...rent ways. However, they have suggested that thi...er their kids from co-educational to segregated sc...American educator Michael Gurian, at a conference ...
...co will kill a billion people this century, 10 tim... unless the countries take serious action to preve...re assuming that by putting one cigarette to your ...if you sniff-up someone else's smoke only once, yo...
...first manned mission to Mars, it has taken its fir...o you get rid of the body of a dead astronaut on a...the plug be pulled on a critically ill astronaut w...ngering the rest of the crew? Should NASA employ D...
...reveals the war veterans who have come back after ...nt. Due to the exposure to chemicals and other har...o brain regions that are closely linked to learnin...of the department of environmental health at the B...
Other Medicine News:Health News:Boys and Girls are Different by Nature and Learn in Different Ways 2Health News:1 Billion People to Be Killed by Smoking 2Health News:NASA Gets Ready To Address Tough Questions 2Health News:NASA Gets Ready To Address Tough Questions 3Health News:Gulf War Veterans Exhibit Memory Impairment 2
... IOL power calculation software. All A-scans and A...e module with SRK II, SRKT, Holladay Dioptimum and...H 5100e are equipped with corneal compression dete...eadings. The only A-Scan in the world with corneal...
The AccuSonic A-scan makes it easy to obtain extreme accuracy and improved patient outcomes. Obtain accurate measurements with industry leading signal acquisition and processing.
The UD-1000 incorporates the latest ultrasound technology for eyecare specialists. It is the ideal choice for your modern diagnostic laboratory. The UD-1000 combines a powerful B-sector scan system w
The UD-6000 combines all the functions of modern ultrasound diagnostics used in ophthalmology: The latest generation high resolution A/B-sector scanner, a diagnostic A-mode scanner with an optional p
Medicine Products: